HLS Therapeutics has a 164 per cent upside, says Clarus cantechletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cantechletter.com Daily Mail and Mail on Sunday newspapers.
The SEC and DOJ accused a New Jersey-based broker of using insider knowledge to make more than $3.4 million from a scheme involving special purpose acquisition companies.